Works by Holdhoff, Matthias


Results: 59
    1
    2
    3
    4
    5
    6
    7

    Blood-based biomarkers for malignant gliomas.

    Published in:
    Journal of Neuro-Oncology, 2013, v. 113, n. 3, p. 345, doi. 10.1007/s11060-013-1144-0
    By:
    • Holdhoff, Matthias;
    • Yovino, Susannah;
    • Boadu, Osei;
    • Grossman, Stuart
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 393, doi. 10.2967/jnumed.116.178434
    By:
    • Lodge, Martin A.;
    • Holdhoff, Matthias;
    • Leal, Jeffrey P.;
    • Bag, Asim K.;
    • Nabors, L. Burt;
    • Mintz, Akiva;
    • Lesser, Glenn J.;
    • Mankoff, David A.;
    • Desai, Arati S.;
    • Mountz, James M.;
    • Lieberman, Frank S.;
    • Fisher, Joy D.;
    • Desideri, Serena;
    • Xiaobu Ye;
    • Grossman, Stuart A.;
    • Schiff, David;
    • Wahl, Richard L.
    Publication type:
    Article
    17

    A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.

    Published in:
    Tomography: A Journal for Imaging Research, 2023, v. 9, n. 1, p. 362, doi. 10.3390/tomography9010029
    By:
    • Ramesh, Karthik K.;
    • Huang, Vicki;
    • Rosenthal, Jeffrey;
    • Mellon, Eric A.;
    • Goryawala, Mohammed;
    • Barker, Peter B.;
    • Gurbani, Saumya S.;
    • Trivedi, Anuradha G.;
    • Giuffrida, Alexander S.;
    • Schreibmann, Eduard;
    • Han, Hui;
    • de le Fuente, Macarena;
    • Dunbar, Erin M.;
    • Holdhoff, Matthias;
    • Kleinberg, Lawrence R.;
    • Shu, Hui-Kuo G.;
    • Shim, Hyunsuk;
    • Weinberg, Brent D.
    Publication type:
    Article
    18

    Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma.

    Published in:
    Tomography: A Journal for Imaging Research, 2022, v. 8, n. 2, p. 688, doi. 10.3390/tomography8020057
    By:
    • Xu, Karen;
    • Ramesh, Karthik;
    • Huang, Vicki;
    • Gurbani, Saumya S.;
    • Cordova, James Scott;
    • Schreibmann, Eduard;
    • Weinberg, Brent D.;
    • Sengupta, Soma;
    • Voloschin, Alfredo D.;
    • Holdhoff, Matthias;
    • Barker, Peter B.;
    • Kleinberg, Lawrence R.;
    • Olson, Jeffrey J.;
    • Shu, Hui-Kuo G.;
    • Shim, Hyunsuk
    Publication type:
    Article
    19

    Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network.

    Published in:
    Tomography: A Journal for Imaging Research, 2020, v. 6, n. 2, p. 60, doi. 10.18383/j.tom.2019.00022
    By:
    • Jones, Ella F.;
    • Buatti, John M.;
    • Hui-Kuo Shu;
    • Wahl, Richard L.;
    • Kurland, Brenda F.;
    • Linden, Hannah M.;
    • Mankoff, David A.;
    • Rubin, Daniel L.;
    • Tata, Darrell;
    • Nordstrom, Robert J.;
    • Hadjiyski, Lubomir;
    • Holdhoff, Matthias;
    • Schwartz, Lawrence H.
    Publication type:
    Article
    20
    21
    22
    23

    Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ.

    Published in:
    Journal of Neuro-Oncology, 2025, v. 171, n. 1, p. 35, doi. 10.1007/s11060-024-04829-6
    By:
    • Rincon-Torroella, Jordina;
    • Rakovec, Maureen;
    • Kalluri, Anita L.;
    • Jiang, Kelly;
    • Weber-Levine, Carly;
    • Parker, Megan;
    • Raj, Divyaansh;
    • Materi, Josh;
    • Sepehri, Sadra;
    • Ferres, Abel;
    • Schreck, Karisa C.;
    • Aldecoa, Iban;
    • Lucas, Calixto-Hope G.;
    • Sair, Haris I.;
    • Redmond, Kristin J.;
    • Holdhoff, Matthias;
    • Weingart, Jon;
    • Brem, Henry;
    • Sánchez, Josep J. González;
    • Ye, Xiaobu
    Publication type:
    Article
    24
    25
    26
    27

    Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 601, doi. 10.1093/neuonc/noaa015
    By:
    • Lee, Eudocia Q;
    • Weller, Michael;
    • Sul, Joohee;
    • Bagley, Stephen J;
    • Sahebjam, Solmaz;
    • van den Bent, Martin;
    • Ahluwalia, Manmeet;
    • Campian, Jian L;
    • Galanis, Evanthia;
    • Gilbert, Mark R;
    • Holdhoff, Matthias;
    • Lesser, Glenn J;
    • Lieberman, Frank S;
    • Mehta, Minesh P;
    • Penas-Prado, Marta;
    • Schreck, Karisa C;
    • Strowd, Roy E;
    • Vogelbaum, Michael A;
    • Walbert, Tobias;
    • Chang, Susan M
    Publication type:
    Article
    28
    29

    NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.

    Published in:
    Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01875-z
    By:
    • Chang, Michael;
    • Sherief, Mohamed;
    • Ioannou, Maria;
    • Chinnasamy, Viveka;
    • Chen, Lucy;
    • Frost, Michael;
    • Mattson-Hoss, Michelle;
    • Sarnoff, Herb;
    • Kamson, David O.;
    • Holdhoff, Matthias;
    • Mukherjee, Debraj;
    • Bettegowda, Chetan;
    • Rincon-Torroella, Jordina;
    • Croog, Victoria;
    • Huang, Peng;
    • Rodriguez, Fausto J.;
    • Lucas, Calixto-Hope G.;
    • Schreck, Karisa C.
    Publication type:
    Article
    30

    Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies.

    Published in:
    Journal of Medical Internet Research, 2024, v. 26, p. 1, doi. 10.2196/57827
    By:
    • Goodday, Sarah M;
    • Karlin, Emma;
    • Brooks, Alexa;
    • Chapman, Carol;
    • Harry, Christiana;
    • Lugo, Nelly;
    • Peabody, Shannon;
    • Rangwala, Shazia;
    • Swanson, Ella;
    • Tempero, Jonell;
    • Yang, Robin;
    • Karlin, Daniel R;
    • Rabinowicz, Ron;
    • Malkin, David;
    • Travis, Simon;
    • Walsh, Alissa;
    • Hirten, Robert P;
    • Sands, Bruce E;
    • Bettegowda, Chetan;
    • Holdhoff, Matthias
    Publication type:
    Article
    31
    32

    Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.

    Published in:
    2015
    By:
    • Rodón, Jordi;
    • Carducci, Michael;
    • Sepulveda-Sánchez, Juan;
    • Azaro, Analía;
    • Calvo, Emiliano;
    • Seoane, Joan;
    • Braña, Irene;
    • Sicart, Elisabet;
    • Gueorguieva, Ivelina;
    • Cleverly, Ann;
    • Pillay, N.;
    • Desaiah, Durisala;
    • Estrem, Shawn;
    • Paz-Ares, Luis;
    • Holdhoff, Matthias;
    • Blakeley, Jaishri;
    • Lahn, Michael;
    • Baselga, Jose
    Publication type:
    Journal Article
    33

    Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.

    Published in:
    Investigational New Drugs, 2015, v. 33, n. 2, p. 357, doi. 10.1007/s10637-014-0192-4
    By:
    • Rodón, Jordi;
    • Carducci, Michael;
    • Sepulveda-Sánchez, Juan;
    • Azaro, Analía;
    • Calvo, Emiliano;
    • Seoane, Joan;
    • Braña, Irene;
    • Sicart, Elisabet;
    • Gueorguieva, Ivelina;
    • Cleverly, Ann;
    • Pillay, N.;
    • Desaiah, Durisala;
    • Estrem, Shawn;
    • Paz-Ares, Luis;
    • Holdhoff, Matthias;
    • Blakeley, Jaishri;
    • Lahn, Michael;
    • Baselga, Jose
    Publication type:
    Article
    34
    35

    Radiation immunodynamics in patients with glioblastoma receiving chemoradiation.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1438044
    By:
    • Sloan, Lindsey;
    • Sen, Rupashree;
    • Chunnan Liu;
    • Doucet, Michele;
    • Blosser, Lee;
    • Katulis, Lisa;
    • Kamson, David O.;
    • Grossman, Stuart;
    • Holdhoff, Matthias;
    • Redmond, Kristin J.;
    • Harry Quon;
    • Lim, Michael;
    • Eberhart, Charles;
    • Pardoll, Drew M.;
    • Chen Hu;
    • Ganguly, Sudipto;
    • Kleinberg, Lawrence R.
    Publication type:
    Article
    36

    The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1433442
    By:
    • Komlodi-Pasztor, Edina;
    • Escarra-Senmarti, Marta;
    • Bazer, Danielle A.;
    • Bhatnagar, Aastha;
    • Perez Heydrich, Carlos A.;
    • Messmer, Marcus;
    • Ambinder, Richard F.;
    • Gladstone, Douglas E.;
    • Clayton, Laura;
    • Goodrich, Amy;
    • Schoch, Laura;
    • Wagner-Johnston, Nina;
    • VandenBussche, Christopher J.;
    • Peng Huang;
    • Holdhoff, Matthias;
    • Rosario, Maximillian
    Publication type:
    Article
    37
    38
    39
    40

    CloneRetriever: An Automated Algorithm to Identify Clonal B and T Cell Gene Rearrangements by Next-Generation Sequencing for the Diagnosis of Lymphoid Malignancies.

    Published in:
    Clinical Chemistry, 2021, v. 67, n. 11, p. 1524, doi. 10.1093/clinchem/hvab141
    By:
    • Halper-Stromberg, Eitan;
    • McCall, Chad M.;
    • Haley, Lisa M.;
    • Ming-Tseh Lin;
    • Vogt, Samantha;
    • Gocke, Christopher D.;
    • Eshleman, James R.;
    • Stevens, Wendy;
    • Martinson, Neil A.;
    • Epeldegui, Marta;
    • Holdhoff, Matthias;
    • Bettegowda, Chetan;
    • Glantz, Michael J.;
    • Ambinder, Richard F.;
    • Xian, Rena R.
    Publication type:
    Article
    41
    42
    43

    Clinical Outcome Assessment Tools for Evaluating the Management of Gliomas.

    Published in:
    Cancers, 2025, v. 17, n. 10, p. 1659, doi. 10.3390/cancers17101659
    By:
    • Chakravarti, Sachiv;
    • Gupta, Sneha R.;
    • Myneni, Saket;
    • Elshareif, Mazin;
    • Rogers, James L.;
    • Caraway, Chad;
    • Ahmed, A. Karim;
    • Schreck, Karisa C.;
    • Kamson, David O.;
    • Holdhoff, Matthias;
    • Croog, Victoria;
    • Redmond, Kristin J.;
    • Bettegowda, Chetan;
    • Mukherjee, Debraj
    Publication type:
    Article
    44

    ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.

    Published in:
    Acta Neuropathologica, 2024, v. 148, n. 1, p. 1, doi. 10.1007/s00401-024-02785-z
    By:
    • Zhang, Kevin Y.;
    • Parker, Megan;
    • Weber-Levine, Carly;
    • Kalluri, Anita;
    • Gonzalez-Gomez, Ignacio;
    • Raabe, Eric;
    • Dudley, Jonathan C.;
    • Gocke, Christopher;
    • Lin, Ming-Tseh;
    • Zou, Ying;
    • Sherief, Mohamed;
    • Kamson, David O.;
    • Holdhoff, Matthias;
    • Mukherjee, Debraj;
    • Croog, Victoria;
    • Schreck, Karisa C.;
    • Rincon-Torroella, Jordina;
    • Bettegowda, Chetan;
    • Eberhart, Charles G.;
    • Bale, Tejus
    Publication type:
    Article
    45
    46

    Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae150
    By:
    • Holdhoff, Matthias;
    • Ye, Xiaobu;
    • Strowd, Roy E;
    • Nabors, Burt;
    • Walbert, Tobias;
    • Lieberman, Frank S;
    • Bagley, Stephen J;
    • Fiveash, John B;
    • Fisher, Joy D;
    • Desideri, Serena;
    • Surakus, Trisha;
    • Engelhardt, Marc;
    • Kaindl, Thomas;
    • Lane, Heidi A;
    • Litherland, Karine;
    • Grossman, Stuart A;
    • Kleinberg, Lawrence R
    Publication type:
    Article
    47

    Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad087
    By:
    • Holdhoff, Matthias;
    • Nicholas, M Kelly;
    • Peterson, Richard A;
    • Maraka, Stefania;
    • Liu, Li C;
    • Fischer, James H;
    • Wefel, Jeffrey S;
    • Fan, Timothy M;
    • Vannorsdall, Tracy;
    • Russell, Meredith;
    • Iacoboni, Michaella;
    • Tarasow, Theodore M;
    • Hergenrother, Paul J;
    • Dudek, Arkadiusz Z;
    • Danciu, Oana C
    Publication type:
    Article
    48

    A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma.

    Published in:
    Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac006
    By:
    • Ramesh, Karthik;
    • Mellon, Eric A.;
    • Gurbani, Saumya S.;
    • Weinberg, Brent D.;
    • Schreibmann, Eduard;
    • Sheriff, Sulaiman A.;
    • Goryawala, Mohammed;
    • de le Fuente, Macarena;
    • Eaton, Bree R.;
    • Jim Zhong;
    • Voloschin, Alfredo D.;
    • Sengupta, Soma;
    • Dunbar, Erin M.;
    • Holdhoff, Matthias;
    • Barker, Peter B.;
    • Maudsley, Andrew A.;
    • Kleinberg, Lawrence R.;
    • Hyunsuk Shim;
    • Shu, Hui-Kuo G.
    Publication type:
    Article
    49
    50